ALNY Data

Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY) » Social Data - Financial Data - Research - Charts

SpeculatingStocks › Pulse Portal › ALNY Data

Follow Important Email Alerts on Stocks from SpeculatingStocks.com.

Sign up for Our Email Newsletter.

ALNY Social Data

$ALNY | Alnylam Pharmaceuticals, Inc. Social Data » 1) Follower Data, 2) Sentiment Data, 3) Posts Data | Data Mined from SpeculatingStocks Pulse Social Network

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

ALNY Follower Data

Followers: 1

ALNY Sentiment Data

'Buys': 0 | 'Sells': 0

'Buys' Yesterday: 0 | 'Sells' Yesterday: 0

B/S Rating Today: 0 | B/S Rating All-Time: 0

ALNY Posts Data

Avg. Number of Pulses a Day: 0.84 | Total Number of Pulses All-Time: 1174

Total Number of Pulses Yesterday: 0

More: $ALNY (Alnylam Pharmaceuticals, Inc.) Stream, Posts, and Sentiment Page

ALNY Financial Data

ALNY | Alnylam Pharmaceuticals, Inc. Financial Data » 1) Annual Financials, 2) Quarterly Financials, and 3) Key Metrics

Market Cap: $8.25B

ALNY Annual Financials (Most Recent Fiscal Year)

Income Statement:

Revenue: $89.91M

Net Income: $(490.87M)

Cash Flow Statement:

Change in Cash / Cash Equiv.: $451.74M

Balance Sheet:

Cash / Cash Equiv. + ST Investments: $1.69B

Short Term Debt: None

Long Term Debt: $30M

Total Current Assets: $1.76B

Total Current Liabilities: $144.25M

Total Assets: $1.99B

Total Liabilities: $228.3M

Stockholder Equity: $1.77B

Annual ALNY Income Statement

Annual ALNY Cash Flow Statement

Annual ALNY Balance Sheet

ALNY Quarterly Financials (Most Recent Q)

Income Statement:

Revenue: $29.91M

Net Income: $(163.56M)

Cash Flow Statement:

Change in Cash / Cash Equiv.: $(34.49M)

Balance Sheet:

Cash / Cash Equiv. + ST Investments: $1.45B

Short Term Debt: None

Long Term Debt: $30M

Total Current Assets: $1.5B

Total Current Liabilities: $113.66M

Total Assets: $1.79B

Total Liabilities: $168.59M

Stockholder Equity: $1.62B

Quarterly ALNY Income Statement

Quarterly ALNY Cash Flow Statement

Quarterly ALNY Balance Sheet

ALNY Key Metrics

Market Cap: $8.25B

Trailing PE: N/A

Price to Sales (Based on Most Recent Annual Revenue): 91.76

Price to Book (Based on Most Recent Quarter Stockholder Equity): 5.09

Beta: 3.25

More Key ALNY Financial Metrics

Please Give Tips to Others about Insight Gained from ALNY Financials

Share: 1) Share Your Opinion of ALNY, 2) Place a 'Buy' or 'Sell' Sentiment on ALNY

ALNY Research

ALNY | Alnylam Pharmaceuticals, Inc. Research » 1) Share Data, 2) Short Data, 3) Insider Data, and 4) Corporate Data

ALNY Share Data

Outstanding Shares: 100.66M

Shares in Float: 47.42M

ALNY Short Data

Percent of Float Short: 6.75%

Shares Short: 6.02M

ALNY Insider Data

Shares Held by Insiders: 0.40%

Shares Held by Institutions: 90.74%

More ALNY Insider Data

ALNY Corporate Data

CEO: Mr. Barry E. Greene

Employees: 749

More Corporate Data on ALNY

Please Give Tips to Others about Insight Gained from ALNY Research

Share: 1) Share Your Opinion of ALNY, 2) Place a 'Buy' or 'Sell' Sentiment on ALNY

ALNY Charts

ALNY | Alnylam Pharmaceuticals, Inc. Charts » 1) 10-Year, 2) 5-Year, 3) 1-Year, 4) 6-Month, 5) 3-Month, 6) 1-Month, 7) 1-Day

ALNY 10-Year Chart

ALNY 5-Year Chart

ALNY 1-Year Chart

ALNY 6-Month Chart

ALNY 3-Month Chart

ALNY 1-Month Chart

ALNY 1-Day Chart

↻ Update ALNY Data to Most Recent

↻ Update ALNY Symbol Stream